Survival inequalities in patients with lung cancer in France: A nationwide cohort study (the TERRITOIRE Study)-Reference-Cited by-同舟云学术

Survival inequalities in patients with lung cancer in France: A nationwide cohort study (the TERRITOIRE Study)

Published:2017-08-25 Issue:8 Volume:12 Page:e0182798
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Chouaïd Christos,Debieuvre Didier,Durand-Zaleski Isabelle,Fernandes Jérôme,Scherpereel Arnaud,Westeel Virginie,Blein Cécile,Gaudin Anne-Françoise,Ozan Nicolas,Leblanc Soline,Vainchtock Alexandre,Chauvin Pierre,Cotté François-Emery^ORCID,Souquet Pierre-Jean

Funder

Bristol-Myers Squibb

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference33 articles.

1. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012;J Ferlay;Eur J Cancer,2013

2. International Agency for Research on Cancer, World Health Organization. European Cancer Observatory: EUCAN national estimates. 2014. http://eco.iarc.fr/EUCAN/Default.aspx

3. Is the urban excess in lung cancer in Scotland explained by patterns of smoking?;J Pearce;Soc Sci Med,2005

4. Lung cancer incidence and survival in England: an analysis by socioeconomic deprivation and urbanization;SP Riaz;J Thorac Oncol,2011

5. Social differences in lung cancer management and survival in South East England: a cohort study;A Berglund;BMJ Open,2012

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment of unresectable stage III non-small cell lung cancer for patients who are under-represented in clinical trials;Cancer Treatment Reviews;2024-09

2. Investigating socioeconomic disparities in lung cancer diagnosis, treatment and mortality: an Italian cohort study;BMC Public Health;2024-06-07

3. Analyse sémantique de conversations sur le web portant sur le cancer du poumon : étude Web Ethnography-Lung;Bulletin du Cancer;2022-07

4. Long-term hospital resource utilization and associated costs of care for patients initiating nivolumab in advanced non-small cell lung cancer in France;Journal of Medical Economics;2022-05-30

5. Risk factors for early mortality of lung cancer patients in France: A nationwide analysis;Cancer Medicine;2022-05-14